Friday Round Up

Here’s a look at a couple of stories that caught our eye this week: Jasper Therapeutics has had a busy couple of weeks. Recently they announced data from their Phase 1 clinical trial treating people with Myelodysplastic syndromes (MDS). This is a group of disorders in which immature blood-forming cells in the bone marrow become … Continue reading Friday Round Up

Join the World Stem Cell Summit for a virtual conference about stem cells and regenerative medicine

Every year Bernie Siegel and his team at the World Stem Cell Summit (WSCS) put together a conference that highlights various topics in the stem cell and regenerative medicine field. This year, because of the coronavirus pandemic, the conference has adopted an entirely virtual format. The Virtual World Stem Cell Summit, as it is known, … Continue reading Join the World Stem Cell Summit for a virtual conference about stem cells and regenerative medicine

Paving the Way

When someone scores a goal in soccer all the attention is lavished on them. Fans chant their name, their teammates pile on top in celebration, their agent starts calling sponsors asking for more money. But there’s often someone else deserving of praise too, that’s the player who provided the assist to make the goal possible … Continue reading Paving the Way

Latest CIRM TRAN1 awards focus on CAR-based cell therapy to treat cancer

Earlier this week the CIRM ICOC Board awarded $14.5 million to fund three translational stage research projects (TRAN1), whose goal is to support early development activities necessary for advancement to a clinical study or broad end use of a potential therapy. Although all three projects have their distinct area of focus, they all utilize CAR-based … Continue reading Latest CIRM TRAN1 awards focus on CAR-based cell therapy to treat cancer

CIRM Board Approves Continued Funding for SPARK and Alpha Stem Cell Clinics

Yesterday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved $8.5 million to continue funding of the Summer Program to Accelerate Regenerative Medicine Knowledge (SPARK) and Alpha Stem Cell Clinics (ASCC). This past February, the Board approved continued funding for stem cell focused educational programs geared towards undergraduate, masters, pre/postdoctoral, and medical … Continue reading CIRM Board Approves Continued Funding for SPARK and Alpha Stem Cell Clinics

How stem cells play “follow the leader”

Todd McDevitt, PhD Photo courtesy: Gladstone Institutes It’s hard enough trying to follow the movements of individuals in a crowd of people, but imagine how much harder it is to follow the movements of stem cells crowded into a tiny petri dish. Well, researchers at the Gladstone Institutes in San Francisco have done just that. … Continue reading How stem cells play “follow the leader”

CIRM Builds Out World Class Team With 5 New hires

Kevin Marks, CIRM's new General Counsel. Photo courtesy Modern-Counsel.com Following the passage of Proposition 14 CIRM has hired five new employees to help increase the team’s ability to respond to new challenges and responsibilities. Prop 14, which was approved by voters in November 2020, gives CIRM $5.5 billion in new funding. Those funds mean CIRM … Continue reading CIRM Builds Out World Class Team With 5 New hires

Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients

A CIRM-funded clinical trial to help kidney transplant patients avoid the need for anti-rejection or immunosuppressive medications has completed enrollment and transplantation of all patients. Medeor Therapeutics’ MDR-101 Phase 3 multi-center clinical trial involved 30 patients; 20 of them were treated with MDR-101, and 10 control subjects were given standard care. CIRM awarded Medeor, based … Continue reading Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients

New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder

Dr. Donald B. Kohn; Photo courtesy UCLA A study published in the New England Journal of Medicine shows that an experimental form of stem cell and gene therapy has cured 48 of 50 children born with a deadly condition called ADA-SCID. Children with ADA-SCID, (severe combined immunodeficiency due to adenosine deaminase deficiency) lack a key … Continue reading New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder

Friends, Romans, countrymen, lend me your ears – we have a podcast for you.

It seems like everyone, including my dog Freddie, has a podcast these days. So now we do too. According to the Podcasthosting.org website there are some two million podcasts in the world. Make that two million and one. That’s because CIRM is launching its own podcast and doing it with one of the biggest names … Continue reading Friends, Romans, countrymen, lend me your ears – we have a podcast for you.